Linagliptin Tablets 5 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 5 mg
Reference Brands: Tradjenta®(EU & US)
Category: Diabetes
Linagliptin is a DPP-4 inhibitor that increases incretin levels, enhancing insulin secretion and lowering glucagon in a glucose-dependent manner. Benefits include improved glycemic control, low hypoglycemia risk, once-daily dosing, and weight neutrality. Approved in both the USA and EU, it's suitable as monotherapy or in combination therapy.
Product Description:
Linagliptin tablets are approved for the treatment of type 2 diabetes in both the USA and EU. In the USA, they are marketed as Tradjenta®, approved via a New Drug Application (NDA) and regulated under 21 CFR, with labeling for risks like pancreatitis and joint pain. Manufacturers must ensure GMP compliance and implement post-marketing surveillance. In the EU, Linagliptin is authorized as Trajenta® via the centralized procedure, requiring CTD-format submission, a Risk Management Plan (RMP), PSURs, and full pharmacovigilance. For regulatory support, dossier preparation, or B2B sourcing, visit PharmaTradz.com.
Linagliptin Tablets — third party manufacturing & bulk supply
Linagliptin Tablets 5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Linagliptin Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Linagliptin Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Linagliptin is used to improve blood sugar control in adults with type 2 diabetes mellitus. It helps lower blood glucose levels by increasing insulin release and decreasing glucagon secretion in a glucose-dependent manner, and it is used along with diet and exercise.
Linagliptin is a synthetic dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by blocking the DPP-4 enzyme, which increases levels of incretin hormones that regulate insulin and glucagon secretion.
Linagliptin is marketed under the trade name Tradjenta.
Linagliptin (Tradjenta) is manufactured by Boehringer Ingelheim, in collaboration with Eli Lilly and Company in certain markets.
The complete generic name is linagliptin.
The brand name is Tradjenta.
Linagliptin is manufactured in multiple countries, including the USA, EU nations, and India, depending on the brand owner and licensed manufacturers.
Related Products
Pioglitazone Hydrochloride 150Mg Tablet
Strength:
15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Actos (USA)
View Details
Nateglinide
Strength:
60 mg, 120 mg, 180 mg
Form: Tablets
Reference Brands: Starlix (USA)
View Details
Miglitol
Strength:
25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Glyset (USA), Diastabol (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
